30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now

Richard Vincent

Track

Insider profile

Performance

Overall performance
2.2
Performance over holding periods
2.2
30 days 90 days 120 days
Average return -3% 8.2% 15.1%
Success rate 81% 68% 82%
Transactions
9 100% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance

Positions

Position Company Period
Chief Financial Officer, Secretary, Director Sorrento Therapeutics Inc Sept. 1, 2012 - Jan. 30, 2015
Part-time Chief Financial Officer Sorrento Therapeutics Inc Feb. 5, 2010 - Sept. 1, 2012
Richard Vincent's trades of Oncternal Therapeutics Inc's stock


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2023-04-14 2023-04-13
B Purchase
98,725 -16.8%
241.76
US$3,108,385 		98,725 -16.8% 241.76 US$3,108,385
2022-03-28 2022-03-28
B Purchase
1,533 -29.6%
294.08
US$1,562,505 		1,533 -29.6% 294.08 US$1,562,505
2022-03-28 2022-03-25
B Purchase
26,689 -46.7%
173.37
US$86,772 		26,689 -46.7% 173.37 US$86,772
2022-03-28 2022-03-25
B Purchase
5 +0.0%
1.48
US$7 		5 +0.0% 1.48 US$7
2022-03-28 2022-03-25
B Purchase
356 +0.4%
1.45
US$516 		356 +0.4% 1.45 US$516
2022-03-28 2022-03-24
B Purchase
3 +0.0%
1.45
US$4 		3 +0.0% 1.45 US$4
2022-01-31 2022-01-28
B Purchase
2,500 +3.1%
1.65
US$4,125 		2,500 +3.1% 1.65 US$4,125
2022-01-31 2022-01-27
B Purchase
5,000 +6.6%
1.70
US$8,500 		5,000 +6.6% 1.70 US$8,500
2022-01-31 2022-01-27
B Purchase
5,000 +7.1%
1.80
US$9,000 		5,000 +7.1% 1.80 US$9,000